Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
air transport
Alberta Stroke Program Early CT score
algorithm
andexanet
aneurysm, intracranial
angiography, neurologic complications with
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
aptiganel
arterial dissection
arterial dissection, basilar
arterial dissection, carotid
arterial dissection, recurrent
arterial dissection, vertebral
arterial perforation
Asians
aspirin
aspirin, dose of
ataxia
atorvastatin
atrial fibrillation
atrial fibrillation, risk stratification
atrial myxoma
atypical
AURORA
baroreceptors
BASICS trial
basilar artery occlusion
basilar artery plaque
basilar artery stenosis
BASIS trial
BEST trial
blacks
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, lesion of
call 911
cardioseal device
cardiovascular disease
carotid angiogram
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, intracranial
carotid-siphon stenosis
CASSISS trial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
cerebellar infarction
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, adolescent
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, nonarterial territory
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prehospital screening
cerebrovascular accident, prehospital treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, rehabilitation of
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
CHADS-VaSC score
CHANCE Trial
CHOICE trial
cholesterol
citicoline
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clinical trials
clopidogrel
CLOSURE I trial
clot retrieval
collateral circulation
color desaturation
coma
complications
controversies in neurology
coronavirus
cortical infarction, small
cortical vein thrombosis
cost
cost effectiveness
coumarin
COVID-19
craniectomy, decompressive
critical pathway
dabigatran
dabigatran, dose
DAWN stroke trial
decerebrate posture
DEFUSE study
dense basilar artery sign
dense middle cerebral artery sign
diplopia
dipyridamole
disability rating scale, neurological
disability, neurological
diuretic
dizziness
doll's head maneuver
door to imaging time
door to needle time
door to reperfusion time
door to treatment time
drop attacks
dural sinus thrombosis
dysarthria
edema, facial
efficacy
embolic stroke of unknown source
embolism
embolism, paradoxical
embolism, vertebral-basilar artery
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-indications for
endovascular photoacoustic recanalization
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
epidemic
epidemiology of neurology
EPITHET trial
ESCAPE trial
ethics in neurology
EXTEND trial
factor Xa inhibitor
failed medical management
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fibroblast growth factor
gastrointestinal bleeding
gaze palsy
gender
GOLIATH trial
HAS-BLED score
head injury
headache
headache, thunderclap
hemorrhagic diathesis
heparin
heparin, low-molecular-weight
hepatic failure
heprain induced thrombocytopenia
HERMES
herpes simplex encephalitis, diagnosis of
hospital length of stay
hypercoagulable state
hyperintense vessel sign
hypertension
iatrogenic neurologic disorders
idarucizumab
indapamide
informed consent
INR value, time in range
INR values
internal carotid artery
intracerebral hemorrhage
intracranial hemorrhage
intracranial pressure, increased
ischemic core
ischemic penumbra
lawsuit
lipid lowering agent
lipids
liver disease
liver function enzymes
locked-in syndrome
malpractice
mastoiditis
MATCH trial
medical-legal aspects of neurology
MERCI trial
middle cerebral artery
middle cerebral artery atherosclerosis
middle cerebral artery territory infarction
middle cerebral artery, branch occlusion
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
misdiagnosis
mobile interventional stroke teams
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, FLAIR, hyperintense vessels
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, volumetry
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
nystagmus
old age, neurology of
outcome research
palliative care
patent foramen ovale
patent foramen ovale, percutaneous closure
patient information and support
patient selection
Penumbra System
perindopril
platelet inhibiting drugs
platelet inhibiting drugs, combined
POINT trial
pons, infarction of
posterior cerebral artery occlusion
posterior circulation stroke
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
PROGRESS trial
quality of life
ramipril
Rankin score
RAPID CT perfusion maps
recanalization, arterial
recanalization, venous
recurrent
rehabilitation for neurologic disorders
RELY trial
reperfusion
research
RESPECT trial
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
screening
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPARCL trial
SPORTIF trial
STARFlex septal closure system
statin therapy
stent, carotid artery
stent, coronary artery
stent, intracranial
stent, middle cerebral artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke unit, mobile
subarachnoid hemorrhage
subdural hematoma
superior sagittal sinus thrombosis
SWIFT PRIME Trials
SWIFT trial
symptomatic
T lesion of MCA-ICA
telemedicine
teleneurology
telestroke
tenecteplase
thrombectomy
thrombectomy, distal occlusion
thrombin inhibitor
thromboaspiration
thrombolysis, mechanical
time is brain
TIMELESS trial
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
trauma
treatment delay
treatment of neurologic disorder
Trevo retriever
trial design
unconsciousness
unconsciousness, transient
urokinase
vaccination, neurologic complications with
vaccine
vertebral artery
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, atherosclerosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vision, blurred
VISSIT trial
visual field defect
WAKE-UP trial
WASID trial
weakness, generalized
Wingspan study
workup
ximelagatran
Showing articles 1550 to 1600 of 2192 << Previous Next >>

Factors Determining the Therapeutic Window for Stroke
Neurol 50:599-603, Zivin,J.A., 1998

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998

Selective Intra-arterial Fibrinolysis of Acute Central Retinal Artery Occlusion
Stroke 29:2076-2079, Weber,J.,et al, 1998

Aspirin and Risk of Hemorrhagic Stroke
JAMA 280:1930-1935,1949, He,J.,et al, 1998

Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998

Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998

Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998

Anticoagulation Therapy in Pediatric Patients with Sinovenous Thrombosis,A Cohort Study
Arch Neurol 55:1533-1537, deVeber,G.,et al, 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998

Diagnosis of Cerebral Venous Thrombosis with Routine Magnetic Resonance: An Update
Eur Neurol 40:179-190, Bianchi,D.,et al, 1998

Ticlopidine and Thrombotic Thrombocytopenic Purpura
NEJM 337:1245, Kupfer,Y.&Tessler,S., 1997

Epidural/Spinal Hematoma with Low Molecular Weight Heparin & Spinal/Epidural Anesth or Spinal Puncture
FDA Advisory, Dec 151997., , 1997

Lubeluzole Treatment of Acute Ischemic Stroke
Stroke 28:2338-2346, Grotta,J., 1997

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

Treatment of Acute Ischemic Stroke with Piracetam
Stroke 28:2347-2352, DeDeyn,P.P.,et al, 1997

Total Quality Improvement Method for Reduct of Delays Between ER Dept Adm & Trtm of Acute Ischemic Stroke
Arch Neurol 54:1466-1474, Tilley,B.C.,et al, 1997

Does Daily Aspirin Diminish Severity of First-Ever Stroke
Arch Neurol 54:1369-1371, Karepov,V.,et al, 1997

Acute Stroke:Usefulness of Early CT Findings Before Thrombolytic Therapy
Radiology 205:327-333, von Kummer,R.,et al, 1997

Generalized Efficacy of t-PA for Acute Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2119-21251997., , 1997

Should Thrombolytic Therapy be the First-Line Treatment for Acute Ischemic Stroke
NEJM 337:1309-1313, Caplan,L.R.,et al, 1997

Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997

Pharmacological Elevation of Blood Pressure in Acute Stroke
Stroke 28:2133-2138, Rordorf,G.,et al, 1997

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997

When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997

Prethrombolysis Brain Imaging:Trends and Controversies
AJNR 18:1830-1834, Castillo,M., 1997

Outcome of Aneurysmal Subarachnoid Hemorrhage in Patients on Anticoagulant Treatment
Stroke 28:6-9, Rinkel,G.E.J.,et al, 1997

Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997

Variables Associated with Hospital Arrival Time After Stroke
Stroke 28:537-542, Azzimondi,G.,et al, 1997

Pitfalls and Potential of Clinical Diffusion-Weighted MR Imaging in Acute Stroke
Stroke 28:481-482, Warach,S.,et al, 1997

Local Thrombolytic Therapy in Deep Cerebral Venous Thrombosis
Neurol 48:1613-1619, Smith,A.G.,et al, 1997

Endovascular Thrombolysis in Deep Cerebral Venous Thrombosis
AJNR 18:502-506, Spearman,M.P.,et al, 1997

Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Ischemic Stroke After Acute Myocardial Infarction
Stroke 28:762-767, Mooe,T.,et al, 1997

Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997

Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997

Does Paroxysmal Atrial Fibrillation Confer a Paroxysmal Thromboembolic Risk
Lancet 349:1565-1566, Lip,G.Y.H., 1997

Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997

Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997

Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997

Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997

Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997

A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997

CAST:Random Placebo-Controlled Trial of Early Aspirin Use in 20000 Pts with Acute Ischaemic Stroke
CAST Collab Grp, Lancet 349:1641-16491997., , 1997

Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997

Predictors of Hemorrhagic Transform Occurring Spont & On Anticoagulants in Pts with Acute Ischemic Stroke
Stroke 28:1198-1202, Alexandrov,A.V.,et al, 1997

Stroke Patients'Knowledge of Stroke
Stroke 28:912-915, Williams,L.S.,et al, 1997



Showing articles 1550 to 1600 of 2192 << Previous Next >>